Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-In-Human Phase I Study”
Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0737-y
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Springer Science and Business Media LLC